Home
Statistics
Acknowledgment
Enquire
Keyword Search
Complex Search
Segment Search
Peptide Mapping
Browse On
Mode of delivery
Animal model
Origin/Source
Peptide Length
Similarity
BLAST Search
Smith-Waterman
General
Help or Guide
Data Submission
Curators
Developers
Contact Us
Browse result page of B3Pdb
The total number entries retrieved from this search are
507
, scroll left/right for detailed information.
B3pdbID
PEPTIDE NAME
PEPTIDE SEQUENCE (1-letter)
PEPTIDE SEQUENCE (3-letter)
N-TERMINAL MODIFICATION
C-TERMINAL MODIFICATION
CHEMICAL MODIFICATION
PEPTIDE LENGTH
PEPTIDE CONFORMATION
PEPTIDE NATURE
SOURCE/ORIGIN OF PEPTIDE
SMILES
CELL LINE
In vitro
CONCENTRATION
In vitro
METHOD
In vitro
RESULT
ANIMAL MODEL
In vivo
CONCENTRATION
In vivo
MODE OF DELIVERY
In vivo
METHOD
In vivo
RESULT
ACTION
TRANSPORT TYPE
SUBCELLULAR LOCALISATION
COMBINATION
PHYSICAL CONDITION
RESPONSE
RESULT
LABEL
PMID
b3pdb_0257
Endmorphin analog -8
H-Dmt-PW-(S,S)-AMBF-NH2
H-Dmt-Pro-Trp-(S,S)-AMBF-NH2
NA
NA
Addition of alpha-methyl-beta-furylalanine
NA
Linear
Cationic
Chemically synthesized
NA
Delta opioid receptor
50 microlitre
HPLC
297 +/- 14 ki value
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0268
D-[Ala]-Peptide T-Am
aSTTTNYT-NH2
NA
NA
NA
NA
8
Linear
NA
Chemically synthesized
NA
NA
NA
Mice
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
3440215
b3pdb_0415
Octreotide
fCFwKTCT
(D)Phe-Cys-Phe-(D)Trp-Lys-Thr-Cys-Thr
NA
NA
Cys2-Cys7
8
Linear
NA
Chemically synthesized
O=C(O)[C@@H](NC(=O)[C@H]2NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](N)Cc1ccccc1)CSSC2)Cc3ccccc3)Cc5c4ccccc4nc5)CCCCN)[C@H](O)C)[C@H](O)C
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0416
Vapreotide
fCYwKVCW-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Trp-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)Cc7c6ccccc6nc7
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.0000923 mL/(g x min)
Direct iodination
1975697
b3pdb_0417
Vapreotide
fCYwKVCW-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Trp-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)Cc7c6ccccc6nc7
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial distribution volume
0.0137 ml/g
Direct iodination
1975697
b3pdb_0418
Vapreotide
fCYwKVCW-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Trp-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)Cc7c6ccccc6nc7
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
half life, serum
1.05 min
Direct iodination
1975697
b3pdb_0419
Vapreotide
fCYwKVCW-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Trp-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)Cc7c6ccccc6nc7
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
half life, brain
24 min
Direct iodination
1975697
b3pdb_0420
Vapreotide
fCYwKVCW-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Trp-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)Cc7c6ccccc6nc7
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
Brain elemination rate constant
0.029 min-1
Direct iodination
1975697
b3pdb_0421
Vapreotide
fCYwKVCW-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Trp-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)Cc7c6ccccc6nc7
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Permeability surface area cofficient
20.3 µL/(g x min)
Direct iodination
1975697
b3pdb_0422
Vapreotide
fCYwKVCW-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Trp-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)Cc7c6ccccc6nc7
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% injected dose
41.6 %/g
Direct iodination
1975697
b3pdb_0423
Vapreotide
fCYwKVCW-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Trp-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)Cc7c6ccccc6nc7
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% injected dose
36.9 %/g
Direct iodination
1975697
b3pdb_0593
[Glu4] Deltorphin
YaFEVVG-NH2
Tyr-(D)Ala-Phe-Glu-Val-Val-Gly-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(N)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)CCC(=O)O)C(C)C)C(C)C
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0594
SAM 995
YtGFLS-NH2
Tyr-(D)Thr-Gly-Phe-Leu-Ser-NH2
NA
NA
NA
6
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C(O)C)Cc2ccccc2)CC(C)C)CO
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
saturable
NA
NA
NA
Volume of donor compartment
0.1678 ml/g
NA
1357139
b3pdb_0596
E2078
CH3-YGGFLR-CH3R-l-NHC2H5
CH3-Tyr-Gly-Gly-Phe-Leu-Arg-CH3Arg-(D)Leu-NHC2H5
NA
NA
NA
8
Linear
NA
Chemically synthesized
O=C(NCC)[C@H](NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC)Cc1ccc(O)cc1)Cc2ccccc2)CC(C)C)CCCNC(=[N@H])N)C)CCCNC(=[N@H])N)CC(C)C
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0597
Ebiratide
M(O2)-EHFkF-NH-(CH2)8-NH2
Met(O2)-Glu-His-Phe-(D)Lys-Phe-NH-CH2)8-NH2
NA
NA
NA
6
Linear
NA
Chemically synthesized
O=C(NCCCCCCCCN)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCS(=O)(=O)C)CCC(=O)O)Cc1ncnc1)Cc2ccccc2)CCCCN)Cc3ccccc3
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0604
Human Beta Defensin-
GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP
Gly-Ile-Gly-Asp-Pro-Val-Thr-Cys-Leu-Lys-Ser-Gly-Ala-Ile-Cys-His-Pro-Val-Phe-Cys-Pro-Arg-Arg-Tyr-Lys-Gln-Ile-Gly-Thr-Cys-Gly-Leu-Pro-Gly-Thr-Lys-Cys-Cys-Lys-Lys-Pro
NA
NA
Cys8-Cys37, Cys15-Cys30, Cys20-Cys38
41
Linear
NA
Chemically synthesized
[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC1=O)[C@@H](C)CC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CSSC[C@H](NC2=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N3)[C@@H](C)O
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0658
Des-octanoyl ghrelin
GSSFLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
NA
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional flux rate constant
0.000573 mL/(g x min)
Direct iodination
12130749
b3pdb_0659
Des-octanoyl ghrelin
GSSFLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
NA
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Initial distribution vaolume
0.011 ml/g
Direct iodination
12130749
b3pdb_0660
Des-octanoyl ghrelin
GSSFLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
NA
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% injected dose
0.02 %/g
Direct iodination
12130749
b3pdb_0661
Des-octanoyl ghrelin
GSSFLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
NA
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
Shake Flask
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Log P
-1.95
Direct iodination
12130749
b3pdb_0662
Des-octanoyl ghrelin
GSSFLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.0007944 mL/(g x min)
Direct iodination
30293893
b3pdb_0663
Des-octanoyl ghrelin
GSSFLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.001775 ml/g
Direct iodination
30293893
b3pdb_0664
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
0.0183 min-1
Direct iodination
12750431
b3pdb_0665
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
half life, brain
37.8 min
Direct iodination
12750431
b3pdb_0666
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
% injected dose
26.56 %/g
Direct iodination
12750431
b3pdb_0667
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional flux rate constant
0.00234 mL/(g x min)
Direct iodination
12750431
b3pdb_0668
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
non saturable
NA
NA
NA
% parenchyma
69%
Direct iodination
12750431
b3pdb_0669
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
non saturable
NA
NA
NA
Capillary depletion (capillary/serum)
0.0011 ml/g
Direct iodination
12750431
b3pdb_0670
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
non saturable
NA
NA
NA
Capillary depletion (parenchyma/serum)
0.00247 ml/g
Direct iodination
12750431
b3pdb_0671
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
non saturable
NA
NA
NA
% capillary
31%
Direct iodination
12750431
b3pdb_0672
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.00049 mL/(g x min)
Direct iodination
12750431
b3pdb_0673
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.012 ml/g
Direct iodination
12750431
b3pdb_0674
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
% injected dose
0.176 %/g
Direct iodination
12750431
b3pdb_0682
[p-Cl-Phe4]-[(D)Pen2
Y-(D)Pen-G-(Cl)F-(D)Pen
Tyr-(D)Pen-Gly-(Cl)Phe-(D)Pen
NA
NA
(D)Pen2-(D)Pen5
5
Linear
NA
Chemically synthesized
O=C(O)[C@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](N)Cc1ccc(O)cc1)C(SSC2(C)C)(C)C)Cc3ccc(Cl)cc3
NA
NA
BMEC
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Permeability coefficient
0.000137933 cm/s
NA
8371162
b3pdb_0683
Enterostatin
VPDPR
Val–Pro–Asp–Pro–Arg
NA
NA
NA
5
Linear
NA
Chemically synthesized
O=C(O)[C@@H](NC(=O)[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)[C@H](O)C)[C@H](O)C
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0684
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Initial distribution vaolume
0.0191 ml/g
H3/C14
8996221
b3pdb_0685
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional flux rate constant
0.00161 mL/(g x min)
H3/C14
8996221
b3pdb_0686
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
71.50%
Direct iodination
20347901
b3pdb_0687
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
28.50%
Direct iodination
20347901
b3pdb_0688
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
44%
H3/C14
8996221
b3pdb_0689
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
56%
H3/C14
8996221
b3pdb_0690
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
half life, serum
60 min
Direct iodination
20347901
b3pdb_0691
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
half life, brain
119 min
Direct iodination
20347901
b3pdb_0692
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
Shake Flask
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Log P
-1.42
H3/C14
8996221
b3pdb_0693
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
-0.000023 mL/(g x min)
Direct iodination
20347901
b3pdb_0694
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.01959 ml/g
Direct iodination
20347901
b3pdb_0697
LSZ 1025
YcGFc-(β-D-Glc)SG-NH2
Tyr-(D)Cys-Gly-Phe-(D)Cys-(β-D-Glucose)Ser-Gly-NH2
(D)Cys2-(D)Cys5
7
Linear
NA
Chemically synthesized
O=C(N)CNC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CSSC2)Cc3ccccc3)CO[C@@H]4OC(CO)[C@H](O)C(O)[C@H]4O
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant,initial
0.00157 ml/(g x min)
Direct iodination
11033091
b3pdb_0698
LSZ 1025
YcGFc-(β-D-Glc)SG-NH2
Tyr-(D)Cys-Gly-Phe-(D)Cys-(β-D-Glucose)Ser-Gly-NH2
NA
NA
(D)Cys2-(D)Cys5
7
Linear
NA
Chemically synthesized
O=C(N)CNC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CSSC2)Cc3ccccc3)CO[C@@H]4OC(CO)[C@H](O)C(O)[C@H]4O
NA
NA
Shake Flask
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Log D
-1.31
Direct iodination
11033091
b3pdb_0699
LSZ 62
YcGFc-(α-D-Glc)SG-NH2
Tyr-(D)Cys-Gly-Phe-(D)Cys-(α-D-Glucose)Ser-Gly-NH2
(D)Cys2-(D)Cys5
7
Linear
NA
Chemically synthesized
O=C(N)CNC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CSSC2)Cc3ccccc3)CO[C@H]4OC(CO)[C@H](O)C(O)[C@@H]4O
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant,initial
0.00133 ml/(g x min)
Direct iodination
11033091
b3pdb_0700
LSZ 62
YcGFc-(α-D-Glc)SG-NH2
Tyr-(D)Cys-Gly-Phe-(D)Cys-(α-D-Glucose)Ser-Gly-NH2
NA
NA
(D)Cys2-(D)Cys5
7
Linear
NA
Chemically synthesized
O=C(N)CNC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CSSC2)Cc3ccccc3)CO[C@H]4OC(CO)[C@H](O)C(O)[C@@H]4O
NA
NA
Shake Flask
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Log D
-1.161
Direct iodination
11033091
previous
1
2
3
4
5
6
7
8
9
10
11
next
IIITD/CB
Raghava's Group
IMTECH
CellPPDMOD